With more than $683 million in funding received from the National Institutes of Health (NIH), the school also had the highest ...

With support from a new National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award F30 award, Oakland is exploring an approach that uses DNA-like molecules that imitate ...

Findings could pave the way for more personalized treatments for cardiovascular disease.

So there’s talk that Robert F. Kennedy Jr will defund the NIH.  Or something like that.  In full disclosure, I am not a fan of the man.  But, I also view the hysteria of academics and ...

Siga Technologies' antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among ...

While disruption is likely if nominee for NIH Director, Bhattacharya, is confirmed by the Senate, the kinds of changes the ...

Jay Bhattacharya would consider the academic freedom at universities and medical schools applying for NIH research grants.

The letter Tuberville signed says the senators “oppose taxpayer funding going toward gender transition interventions for ...

Interim data from a phase 3 study evaluating tecovirimat for the treatment of human mpox virus showed the antiviral did not improve time to lesion resolution compared with placebo.

Dr. Andrea Cercek, a medical oncologist from Memorial Sloan Kettering Cancer Center, and colleagues reported that the use of ...

The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild ...

But come January, when President-elect Donald Trump and congressional Republicans take charge, the NIH may face a reckoning.